Paul C.M.S. Verhagen

Author

Also Known As

P Verhagen, P. C. M. S. Verhagen, P. C.M.S. Verhagen, P. Verhagen, P.C.M.S. Verhagen, PAUL C. M. S. VERHAGEN, Paul C Verhagen, Paul C. M. S. Verhagen, Paul C. Verhagen, Paul C.M.S Verhagen

Publications

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam Amsterdam UMC Location University of Amsterdam OLVG Rotterdam University of Applied Sciences

About

Paul C.M.S. Verhagen is an author at Erasmus MC specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.6K
2	Nephrology	2	2	29
3	Health Sciences	1	1	34
4	Endocrinology	1	1	40
5	Pathology	1	1	29

Paul C.M.S. Verhagen

Publications

Citations

H-Index

Page 1

	Year	Citations
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) M. Bolla, Hendrik Van Poppel, Bertrand Tombal, The Lancet Radiation MedicineSurgical OncologyUrologyRadiation TherapyHigh-risk Prostate Cancer	2012	856
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, European Urology UrologyRadiation MedicineRadiation TherapyMedicineHorrad Trial	2018	554
Overexpression of Prostate-Specific <i>TMPRSS2(exon 0)-ERG</i> Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer Karin G. Hermans, Joost L. Boormans, Delila Gasi Tandefelt, Clinical Cancer Research	2009	89
Kidney and Urinary Tract Imaging: Triple-Bolus Multidetector CT Urography as a One-Stop Shop—Protocol Design, Opacification, and Image Quality Analysis Maka Kekelidze, Roy S. Dwarkasing, Marcel L. Dijkshoorn, Radiology	2010	82
Percutaneous nephrolithotomy for treating renal calculi in children Joost L. Boormans, Jeroen R. Scheepe, Carl F. Verkoelen, British Journal of Urology	2005	49
Histopathological characteristics of lymph node metastases predict cancer‐specific survival in node‐positive prostate cancer Joost L. Boormans, Mark F. Wildhagen, Chris H. Bangma, British Journal of Urology	2008	48
Expression of the Androgen-Regulated Fusion Gene TMPRSS2-ERG Does Not Predict Response to Endocrine Treatment in Hormone-Naïve, Node-Positive Prostate Cancer Joost L. Boormans, Karin G. Hermans, Angelique C. J. Ziel-van der Made, European Urology UrologyHormonal ReceptorEndocrine TreatmentPredict ResponseEndocrinology	2009	40
Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, Paul C.M.S. Verhagen, European Urology Quality Of LifeUrologyRadiation TherapyMedicinePatient-reported Quality	2020	34
Surgical Anatomy of the 10th and 11th Intercostal, and Subcostal Nerves: Prevention of Damage During Lumbotomy Teunette van der Graaf, Paul C.M.S. Verhagen, A.L.A. Kerver, The Journal of Urology	2011	33
Diagnostic Value of Urinary Dysmorphic Erythrocytes in Clinical Practice Meindert J. Crop, Yolanda B. de Rijke, Paul C.M.S. Verhagen, Nephron Clinical Practice	2010	30

Page 1